Expression of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Receptor DR5 in Ewing Sarcoma Family Tumors (ESFT)

被引：0
|
作者：
Galli, S. [1 ]
Li, G. [1 ]
Ren, Y. [1 ]
Tsokos, M. [1 ]
机构：
[1] NCI, NIH, Bethesda, MD 20892 USA
来源：
LABORATORY INVESTIGATION | 2009年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1569
引用
收藏
页码：346A / 346A
页数：1
相关论文
共 50 条
  • [41] Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells
    Alexandre Nesterov
    Yuri Ivashchenko
    Andrew S Kraft
    Oncogene, 2002, 21 : 1135 - 1140
  • [42] Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediates tumor immune evasion in cholangiocarcinoma.
    Loeuillard, Emilien
    Yang, Jingchun
    Dong, Haidong
    Gores, Gregory J.
    Ilyas, Sumera
    CANCER RESEARCH, 2021, 81 (13)
  • [43] The Coumarin Psoralidin Enhances Anticancer Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)
    Bronikowska, Joanna
    Szliszka, Ewelina
    Jaworska, Dagmara
    Czuba, Zenon P.
    Krol, Wojciech
    MOLECULES, 2012, 17 (06) : 6449 - 6464
  • [44] Synthetic Flavanones Augment the Anticancer Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)
    Szliszka, Ewelina
    Kostrzewa-Suslow, Edyta
    Bronikowska, Joanna
    Jaworska, Dagmara
    Janeczko, Tomasz
    Czuba, Zenon P.
    Krol, Wojciech
    MOLECULES, 2012, 17 (10) : 11693 - 11711
  • [45] Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene
    Kagawa, S
    He, C
    Gu, J
    Koch, P
    Rha, SJ
    Roth, JA
    Curley, SA
    Stephens, LC
    Fang, BL
    CANCER RESEARCH, 2001, 61 (08) : 3330 - 3338
  • [46] Dammarenolic acid sensitizes cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
    Kroeger, A.
    Proksch, P.
    Kampkoetter, A.
    Waetjen, W.
    Kahl, R.
    Chovolou, Y.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 72 - 72
  • [47] Mechanisms of sensitivity and resistance of melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
    Kurbanov, B. M.
    Fecker, L. F.
    Sterry, W.
    Eberle, J.
    EXPERIMENTAL DERMATOLOGY, 2007, 16 (03) : 263 - 263
  • [48] The Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Lung Cancer Still Following the Right TRAIL?
    McGrath, Emmet E.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : 983 - 987
  • [49] Targeting Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL): A Promising Therapeutic Strategy in Gliomas
    Alexiou, George A.
    Tsamis, Konstantinos I.
    Kyritsis, Athanasios P.
    SEMINARS IN PEDIATRIC NEUROLOGY, 2015, 22 (01) : 35 - 39
  • [50] Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene
    Kagawa, S
    Fujiwara, T
    Tsunemitsu, Y
    Ohtani, S
    Fang, B
    Roth, J
    Tanaka, N
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S143 - S143
12345